How To Invest
In addition, Pat thinks then beginner investors should cultivate two important qualities: a healthy sense of skepticism and patience.
Investors should approach all investments with a healthy sense of skepticism. This can help keep you out of fraudulent stocks that masquerade as high-quality stocks. It will also keep you out of legally operated, but poorly managed, companies that promise more than they can possibly deliver.
If you are a new investor, you should also realize that losing patience can cause you to sell your best choices right before a big rise. All too often, investors buy a promising stock just as it enters a period of price stagnation. Even the best-performing stocks run into these unpredictable phases from time to time. They move mainly sideways in a wide range for months or years before their next big rise begins. (Stock brokers often refer to these stocks as “dead money.”)
If you lack patience, you run a big risk of selling your best choices in the midst of one of these phases, prior to the next big move upward. If you lose patience and sell, you are particularly likely to do so in the low end of the trading range, when stock prices have weakened and confidence in the stock has waned.
[text_ad use_category="18"]
Read More
Close
DIAMONDS TRUST SHARES $114 (American Exchange symbol DIA; buy or sell through brokers) hold the 30 stocks that make up the Dow Jones Industrial Average. Expenses are about 0.18% of assets. Currently, the fund’s top 10 holdings are IBM, 3M, Boeing Co., United Technologies, Caterpillar, Altria Group, American International Group, Johnson & Johnson, Procter & Gamble and Exxon Mobil....
S&P DEPOSITORY RECEIPTS $131 (American Exchange symbol SPY; buy or sell through brokers) are commonly called ‘Spiders’. The fund holds the stocks in the S&P 500 Index. This index is comprised of 500 major U.S. stocks chosen for market size, liquidity, and industry group representation....
NASDAQ-100 TRUST SHARES $41.49 (Nasdaq Exchange symbol QQQQ; buy or sell through brokers) or ‘Qubes’, hold the stocks that represent the Nasdaq-100 Index. This index is made up of the 100 largest and most heavily traded stocks on the Nasdaq Exchange. The index reflects firms across major industry groups including computer hardware and software, telecommunications, retail/wholesale trade and biotechnology. It does not contain financial companies. Expenses are about 0.20% of assets. At last report, the top 10 highest-weighted stocks were Qualcomm, Microsoft, Apple Computer, Google, Cisco, Intel, Amgen, eBay, Oracle and Starbucks. Nasdaq-100 Trust Shares are a buy for aggressive investors only.
ISHARES CDN LARGECAP 60 INDEX FUND $68.83 (Toronto symbol XIU; buy or sell through a broker) (formerly called iUnits S&P/TSX 60 Index Participation Fund) is a good low-fee way to buy the top stocks on the TSE. The units hold a basket of stocks that represent the S&P/TSX 60 Index. The index is made up of the 60 largest and most heavily traded stocks on the TSE. Most of the 60 stocks in the index are good quality companies. However, to meet the requirement that all sectors are represented, the index holds a few firms we wouldn’t include, such as Abitibi-Consolidated, Quebecor World and Rogers Communcations. The index’s top holdings are: Royal Bank, 6.4%; Manulife, 6.1%; EnCana Corporation, 5.2%; Bank of Nova Scotia, 4.8%; TD Bank, 4.8%; Suncor Energy, 4.8%; Canadian Natural Resources, 3.9%; Bank of Montreal, 3.4%; Barrick Gold, 3.2%; Petro-Canada, 3%; CIBC, 3%; Sun Life Financial, 2.9%; and Canadian National Railway, 2.9%....
TRIMARK CANADIAN RESOURCES FUND $18.17 (CWA Rating: Aggressive) (AIM Funds Management Inc., 5140 Yonge Street, Suite 900, Toronto, Ontario M2N 6X7. 1-800-631-7008; Website: www.aimfunds.ca. Buy or sell through brokers.) includes firms we’d rate as Speculative in its top picks. However, we like the fund’s value-seeking, conservative approach to picking stocks in the volatile resource sector. The $459.9 million fund’s MER is 2.47%. Over the last year, Trimark Canadian Resources made 34.7%. Its five-year record is 26.2% annually. The fund’s top holdings are West Fraser Timber, Kinross Gold Corporation, Barrick Gold, Inmet Mining, Mayr-Melnhof Karton AG (Austrian cardboard carton maker), Enerflex Systems, Inco Ltd., Labrador Iron Ore Royalty, Teck Cominco and Sherritt International....
TD RESOURCE FUND $31.13 (CWA Rating: Aggressive) (TD Asset Management, P.O. Box 7500, Station A, Toronto, Ontario. M5W 1P9. 1-800-463-3863; Web ite:www.tdcanadatrust.ca. No load — deal directly with the bank) invests in companies with superior asset bases, proven management and the ability to internally finance growth. The $240.5 million TD Resource Fund’s top holdings are mostly of ‘Average’ quality or higher. They include Suncor Energy, Alcan, EnCana, Talisman Energy, Cameco Corp., Shell Canada, Petro-Canada, Nexen and Western Oil Sands. The fund’s industry breakdown is: Energy, 48.6%; and Materials, 44%. Its MER is 2.45%. Over the past year the fund has made 45.1%. The fund’s five-year average is 24.0% annually. TD Resource Fund is a buy.
ALTAMIRA SCIENCE & TECHNOLOGY FUND $8.45 (CWA Rating: Aggressive) (Altamira Investment Services, The Exchange Tower, 130 King St. West, Suite 900, Toronto, Ont. M5X 1K9. 1-800-263-2824; Web site: www.altamira.com. No load — deal directly with the company) invests in the telecommunications, biotechnology, environmental technology, health care and computer industries. The $72.9 million fund gained 1.1% over the last year, compared to the Nasdaq’s gain of 2.8%. Its MER is 2.68%. Top holdings include: Cisco, 6.2%; Microsoft, 4.4%; ASML Holding, 4.0%; Intel, 3.6%; Verisign, 3.5%; Yahoo!, 3.4%; Nokia, 3.3%; Samsung, 3.3%; Red Hat, 3.2%; and St. Jude Medical, 2.8%....
MANULIFE FINANCIAL $73 (Toronto symbol MFC; SI Rating: Above-average) sells life and other forms of insurance, as well as mutual funds and investment management services. It operates in 19 countries and territories worldwide. Manulife has assets under administration of $372.3 billion. Manulife acquired New York-listed John Hancock Financial Services in 2003 for $15 billion in shares. The merger was one of the largest ever in the life insurance industry, but the integration has gone smoothly. John Hancock continues to add to Manulife’s sales and profits in the U.S. In the three months ended December 31, 2005, Manulife’s earnings rose 18.3%, to $900 million or $1.14 a share, from $761 million or $0.93 a share a year earlier. Revenue rose 3.6%, to $8.20 billion from $7.92 billion. The shares yield 1.9%....
GREAT-WEST LIFECO $29 (Toronto symbol GWO; SI Rating: Above-average) is a leading Canadian insurance company, with $177.3 billion in assets under administration. The company also provides wealth management and other financial services. It also operates in the U.S. and Europe. Power Corp. of Canada controls about 75% of the company’s common stock. Great-West’s earnings in the three months ended December 31, 2005 rose 10.3%, to $469 million or $0.53 a share from $423 million or $0.48. Revenues rose 13.6%, to $6.52 billion from $5.74 billion. Earnings growth came from the company’s Canadian and European operations. Canada accounts for 38% of total revenues. Canadian earnings in the latest quarter rose 16.7%. European revenues comprise 45% of the total. Earnings in that region rose 9.9%....
TD HEALTH SCIENCES FUND $16.09 (CWA Rating: Speculative) (TD Asset Management, P.O. Box 7500, Station A, Toronto, Ontario. M5W 1P9. 1-800-463-3863; Web site: www.tdcanadatrust.ca. No load — deal directly with the bank) invests mostly in U.S. companies with a mixture of large-capitalization stocks and earlier-stage biotechnology shares. The fund’s managers believe all these firms will profit from an aging population stimulating higher spending by governments and individuals on health care, drugs and research. The fund’s top holdings include WellPoint, Amgen, Sepracor, ImClone Systems, Genentech, Gilead Sciences, UnitedHealth Group, Wyeth, Community Health Systems and Cephalon. Its MER is 2.79%. The $286.4 million fund’s manager is well-known U.S. fund manager T. Rowe Price Associates. TD Health Sciences gained 6.6% over the last year....